Ā 

Pervasis drug candidate gets EU orphan drug status - Mass High Tech PDF Print
Mass High Tech
Pervasis Therapeutics Inc. has won orphan drug designation from the European Commission for its lead drug Vascugel, a prevention treatment of kidney dialysis access failure in patients with end stage renal disease (ESRD). ...
Pervasis Receives Orphan Drug Designation in Europe for VascugelĀ® to Prevent

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.